The effects of site-specific NMDA receptor antagonists on intravenous cocaine self-administration were examined in rats trained to self-administer cocaine [...] The non-competitive NMDA receptor antagonists, dizocilpine (MK-801) and memantine dose-dependently decreased cocaine self-administration, while the competitive NMDA receptor antagonist, CGP 39551, and the NMDA/glycine receptor antagonist, L-701,324, were without effect. Under a progressive ratio (PR) schedule, dizocilpine increased the number of cocaine infusions in a manner similar to increasing the unit dose of cocaine, suggestive of potentiation of cocainereward. Conversely, memantine produced rate-decreasing effects on the PR schedule. These results demonstrate that NMDA receptor antagonists acting at different modulatory sites of the NMDA receptor do not share dizocilpine's cocaine reward enhancing effects although they are all known to be effective blockers of NMDA receptor activity.